Oragenics Inc (OGEN)
1.07
+0.02
(+1.90%)
USD |
NYAM |
May 03, 16:00
1.05
-0.02
(-1.87%)
Pre-Market: 20:00
Oragenics Cash from Financing (Quarterly): -0.1806M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -0.1806M |
September 30, 2023 | 0.7321M |
June 30, 2023 | -0.1079M |
March 31, 2023 | -0.1598M |
December 31, 2022 | -0.088M |
September 30, 2022 | -0.1035M |
June 30, 2022 | -0.1222M |
March 31, 2022 | -0.1812M |
December 31, 2021 | -0.779M |
September 30, 2021 | 0.5783M |
June 30, 2021 | 0.1523M |
March 31, 2021 | 23.19M |
December 31, 2020 | 11.23M |
September 30, 2020 | 5.080M |
June 30, 2020 | 0.0897M |
March 31, 2020 | -0.073M |
Date | Value |
---|---|
December 31, 2019 | -0.0736M |
September 30, 2019 | -0.05M |
June 30, 2019 | -0.13M |
March 31, 2019 | 11.35M |
December 31, 2018 | 9.439M |
September 30, 2018 | 12.39M |
June 30, 2018 | 1.464M |
March 31, 2018 | -0.0416M |
December 31, 2017 | 4.602M |
September 30, 2017 | 2.174M |
June 30, 2017 | 1.679M |
March 31, 2017 | -0.005M |
December 31, 2016 | 0.9394M |
September 30, 2016 | 0.9499M |
June 30, 2016 | 2.596M |
March 31, 2016 | -0.0339M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.779M
Minimum
Dec 2021
23.19M
Maximum
Mar 2021
2.053M
Average
-0.0736M
Median
Dec 2019
Cash from Financing (Quarterly) Benchmarks
Palatin Technologies Inc | 4.974M |
Inogen Inc | -0.014M |
Cyclacel Pharmaceuticals Inc | 0.999M |
Actinium Pharmaceuticals Inc | 14.77M |
MAIA Biotechnology Inc | 5.025M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -1.102M |
Cash from Investing (Quarterly) | -1.00M |
Free Cash Flow | -7.291M |
Free Cash Flow Per Share (Quarterly) | -0.4257 |
Free Cash Flow Yield | -303.0% |